Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms

  title={Bedeutung der Immunhistochemie f{\"u}r die Diagnose des Cholangiokarzinoms},
  author={Florian L{\"a}nger and R. von Wasielewski and Hans H. Kreipe},
  journal={Der Pathologe},
ZusammenfassungDem Immunphänotyp kommt bei der histogenetischen Zuordnung von Karzinomen wachsende Bedeutung zu. Für Cholangiokarzinome (CC) trifft dies zum einen aufgrund der zunehmenden Zahl kleiner diagnostischer Proben mit eingeschränkter morphologischer Aussagekraft zu, zum anderen treten in der Leber eine Vielzahl metastasierter Adenokarzinome mit morphologischen Überlappungen zum CC auf. Zur Immunphänotypisierung von Tumoren können Intermediärfilamente, Glykoproteine, Mukoproteine, Adh… 
5 Citations

Pitfalls in der Klassifikation von Lebertumoren

Difficulties in histological typing of liver tumors, particularly in the differential diagnosis between hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) can be minimized by using immunohistochemistry.


In combination with the fact that a primary tumor cannot be identified by autopsy in more than 20 % of cases, the important conclusion can be drawn that curative approaches seem appropriate for localized CUP cases.

Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma*

This study concludes that stress-induced phosphoprotein 1 should be considered as a potential diagnostic biomarker for CCC in an immunohistochemical application, possibly in combination with other candidates from this study in the form of a biomarker panel.



Immunohistochemical Staining in the Diagnosis of Pancreatobiliary and Ampulla of Vater Adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2

It is concluded that CK17 is a useful marker in separating pancreatobiliary adenocarcinomas from extra-pancreatobiliary nonmucinousAdenocARCinomas, including adenOCarc inomas from the colon, breast, gynecologic organs, stomach, lung, prostate, thyroid, kidney, and adrenal gland, and malignant mesothelioma.

CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas

Uniform CDX2 expression is demonstrated to be an exquisitely sensitive and highly, but incompletely, specific marker of intestinal adenocarcinomas in primary and metastatic epithelial tumors.

Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

The CK immunoprofile of CC varies according to the location of the tumor in the biliary tract, peripheral CC being more often CK7/CK20-, and nonperipheral ones CK7+/Ck20+; and a decision tree based on CK20 LI and CK7 positivity allows the distinction of CRM and CC, even for the nonPeripheral type.

Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis

Aberrant expression of CDX2 is closely related to the overexpression of MUC2 in mucinous ICC and IPNL associated with hepatolithiasia, suggesting its role in intestinal differentiation and its association with carcinogenesis in these tumors.

Combined Hepatocellular–Cholangiocarcinoma: A Histopathologic, Immunohistochemical, and In Situ Hybridization Study

Clinically, CHCs showed many differences from pure hepatocellular carcinoma, including the absence of cirrhosis, rarity of serum hepatitis B or C marker positivity, and normal to only mildly elevated serum alpha-fetoprotein levels, which proves that such an interpretation would not have been accurate.

Immunohistochemistry Can Help Distinguish Metastatic Pancreatic Adenocarcinomas From Bile Duct Adenomas and Hamartomas of the Liver

MCEA showed a reasonably high sensitivity and 100% specificity in the differential diagnosis versus BDA, and p53, TAG-72, mCEA, loss of Dpc4, and mesothelin had the highest specificity for pancreatic adenocarcinoma, with m CEA having the highest sensitivity.

Cytokeratin 5/6 Immunostaining in Hepatobiliary and Pancreatic Neoplasms

For the evaluation of poorly differentiated neoplasms in the liver, immunoreactivity with cytokeratin 5/6 may help to exclude the possibility of hepatocellular carcinoma.

Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.

Hep Par 1 was sensitive and specific for HCC, with 38 of 42 (90%) cases staining positively, whereas reactivity was observed in only 8 of 56 MAs and 0 of 9 CCs, Though limited somewhat by poor sensitivity, a bile canalicular pattern of staining with pCEA, CD10, and villin was specific forHCC and was not observed in the other tumors.

A Comparison of CD10 to pCEA, MOC-31, and Hepatocyte for the Distinction of Malignant Tumors in the Liver

The combination of Hepatocyte, MOC31, and pCEA correctly classified 99 of 100 tumors in this study and is the proposed panel of immunostains for the initial workup of malignant tumors in the liver.

Immunohistochemical Analysis of Biliary Tract Lesions

The presence of bcl-2 and p53 immunoreactivity coupled with a high proliferative rate in a biliary tract lesion suggests a malignant process and a panel using these antibodies may be useful in difficult cases.